Company intelligence / Profile preview

Woodland Capital

Worcester, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Woodland Capital is a private investment and holding company that focuses on the life sciences and healthcare sectors. The firm is notably the parent organization for Woodland Biosciences, a preclinical contract research organization (CRO) specializing in oncology and metabolic diseases, and Woodland Pharmaceuticals, which focuses on drug discovery. Woodland Capital provides strategic financing and operational support to its portfolio companies, leveraging deep expertise in preclinical drug development and disease modeling. The firm's primary objective is to advance innovative therapeutic candidates and research services through its specialized subsidiaries.

Industry: Investors

Beyond the preview

Go deeper on Woodland Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Woodland Capital.

Explore the full profile